Mr Gabriel Luz Saenz, MSN, APRN, PMHNP-BC | |
Bdaach/549th Hc Usag Humphreys, Bldg. #3030, Unit #15245, Apo, AP 96271 | |
(315) 737-2635 | |
Not Available |
Full Name | Mr Gabriel Luz Saenz |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | Bdaach/549th Hc Usag Humphreys, Bldg. #3030, Apo, Armed Forces Pacific |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003298423 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 783012 (Texas) | Secondary |
283Q00000X | Psychiatric Hospital | AP129633 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Gabriel Luz Saenz, MSN, APRN, PMHNP-BC 2902 Traditions Dr, Killeen, TX 76549-6117 Ph: (281) 435-8532 | Mr Gabriel Luz Saenz, MSN, APRN, PMHNP-BC Bdaach/549th Hc Usag Humphreys, Bldg. #3030, Unit #15245, Apo, AP 96271 Ph: (315) 737-2635 |
News Archive
McMaster University researchers have provided evidence of new cancerous cells they have termed cancer regenerating cells, which are responsible for the return of acute myeloid leukemia after remission.
Researchers at LSTM have taken significant steps in understanding the way that the anti-malarial drug primaquine works, which they hope will lead to the development of new, safer and more effective treatments for malaria.
Paracetamol (acetaminophen) is the most commonly used medicine in pregnancy, yet there are very few studies that have investigated the possible long-term consequences for the child. A new study from the Norwegian Institute of Public Health suggests that long-term use of paracetamol during pregnancy may increase the risk of adverse effects on child development.
The ever-changing "head" of an influenza virus protein has an unexpected Achilles heel, report scientists funded by the National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health.
U.S. Renal Care, Inc. (USRC), a leading privately-held provider of outpatient dialysis services, today announced it has started construction of a dialysis center in Grove, Oklahoma, the company's first in the state. The center, expected to open in December 2010, will bring the company's patient total to more than 5,500 served across 85 dialysis centers, home and specialty hospital dialysis programs and facilities. The expansion into northeast Oklahoma is part of USRC's commitment to serving rural communities without dialysis or nephrology services.
› Verified 2 days ago